Skip to main content
. 2019 Dec 17;2019(12):CD013505. doi: 10.1002/14651858.CD013505

Beigi 2006.

Methods RCT
Setting: Iran
Method of randomisation: unclear
Blinding: unclear
Number randomised: 70
Participants Summary: metformin vs CC alone
Inclusion criteria: PCOS based on a history of hyperandrogenism, anovulation, oligomenorrhoea or amenorrhoea, diagnostic US and laboratory findings
Exclusion criteria: unclear
Baseline characteristics of each group: metformin (n = 35) vs CC (n = 35) unclear
Dropouts: unclear
Interventions Main intervention: metformin 500 mg 3/d
Duration: 6 months
Co‐interventions: CC 50 mg 2/d from day 5‐9 of cycle
Outcomes Ovulation: unclear how measured
Others: live birth rate, miscarriage, clinical pregnancy, menstrual frequency
Notes Only abstract found, contacted study authors to provide further information of methodology and results